Strong Buy Recommendation for Precision BioSciences: Promising Clinical Data and Favorable Valuation
BMO Capital analyst Kostas Biliouris upgraded the rating on Precision BioSciences (DTIL – Research Report) to a Buy today, setting a price ...
eLife1d
Early and delayed STAT1-dependent responses drive local trained immunity of macrophages in the spleen
In vivo perturbations and single-cell RNA-seq reveal cell-type-specific STAT1-IFNg signaling in regulation of trained immunity in tissue-resident immune cells.
Cargo Therapeutics, Inc.: CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025
Phase 2 clinical study of firicabtagene autoleucel (firi-cel); Interim analysis results expected to be reported in 1H'25 - - IND application for CRG-023 ...
Dow soars 600 points, S&P, Nasdaq rise over 1.4% after inflation data, strong bank earnings
Wall Street's major indexes surged on Wednesday with the S&P 500 reaching a one-week high due to lower-than-expected core ...
Regenxbio Inc.: Why It Is Down, And When It Will Go Up Again
Undervalued biotech company Regenxbio Inc. shows promise with cutting-edge gene therapy technology for AMD and MPS II. Click ...
OnePlus 13R review: a triple threat of battery, performance, and brilliance
The OnePlus 13R keeps up with the best without splurging on the newest parts, so if you have no desire to part with an ...
Scientific Research Publishing2d
Application and Research Advancement of Antibody-Conjugated Drugs in Non-Small Cell Lung Cancer ()
Huang, B.T., Li, K.F., Wu, X.S., Zhang, F.Y. and Li, Y.P. (2025) Application and Research Advancement of Antibody-Conjugated Drugs in Non-Small Cell Lung Cancer. Journal of Biosciences and Medicines, ...